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Drug treatment and Ca 2+ imaging
Cultured PreOLs were divided into five groups as follows: control group (CTL), OGDtreated group (OGD), catalpol-treated group (CAT), KB-R7943+catalpol-treated group (KB+CAT), and NCX3 antibody+catalpol-treated group (Antibody+CAT). PreOL cultures in the OGD group were incubated in glucose-free DMEM medium (Gibco) with 8 mM Na2S2O4
(Sigma) at 37°C for 30 min to scavenge O2 molecules in solution and to reduce the partial pressure of O2 to zero. Following OGD, the cells were maintained in glucose-containing medium in a 5% CO2-containing atmosphere at 37°C for an additional 12 h. Cells in the CAT group were pretreated with 0.5 mM catalpol for 1 h prior to OGD. Cells in the KB+CAT group were simultaneously pretreated with 10 μM NCX inhibitor KB-R7943 (Sigma) and 0.5 mM catalpol for 1 h prior to OGD. Cells in the Antibody+CAT group were simultaneously pretreated with 2.5 μg/ml NCX3 antibody (Santa Cruz) and 0.5 mM catalpol for 1 h prior to OGD. The CTL group was maintained under a normoxic atmosphere in glucose-containing medium without catalpol, KB-R7943, or NCX3 antibody treatment. Figure S1 ). 
